Home   /   Taxonomy   /   Term

hina Resources Pharmaceutical Group

PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement

PhillipCapital has kept its "buy" recommendation with the same target price of 44.5 cents.
×